ID
12421
Beschrijving
Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®; ODM derived from: https://clinicaltrials.gov/show/NCT02124785
Link
https://clinicaltrials.gov/show/NCT02124785
Trefwoorden
Versies (2)
- 17-11-15 17-11-15 -
- 17-11-15 17-11-15 - Julian Varghese
Geüploaded op
17 november 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hepatitis A NCT02124785
Eligibility Hepatitis A NCT02124785
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
History of hepatitis
Datatype
boolean
Alias
- UMLS CUI [1]
- C1997459
Beschrijving
Hepatitis A Vaccines
Datatype
boolean
Alias
- UMLS CUI [1]
- C0170300
Beschrijving
Immunosuppressive or immunodeficient condition
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021079
- UMLS CUI [2]
- C0021051
Beschrijving
Hepatitis A immunoglobulin
Datatype
boolean
Alias
- UMLS CUI [1]
- C3652495
Beschrijving
Administration of immunosuppressants
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021081
- UMLS CUI [2]
- C0279021
Beschrijving
Administration of long-acting immune-modifying drugs (e.g. infliximab)
Datatype
boolean
Alias
- UMLS CUI [1]
- C1134703
Beschrijving
Study Subject Participation Status
Datatype
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Hepatitis A NCT02124785
- StudyEvent: Eligibility
C0021051 (UMLS CUI [2])
C0279021 (UMLS CUI [2])